Trial Profile
Effect of olmesartan and amlodipine on coronary flow reserve in patients with essential hypertension
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 19 Nov 2012
Price :
$35
*
At a glance
- Drugs Olmesartan medoxomil (Primary) ; Amlodipine
- Indications Hypertension
- Focus Pharmacodynamics
- 19 Nov 2012 New trial record